tiprankstipranks
Immunome (IMNM)
NASDAQ:IMNM
US Market

Immunome (IMNM) Cash flow

183 Followers

Immunome Cash Flow

IMNM's free cash flow for Q1 2024 was $-28.34M. For the 2024 fiscal year, IMNM's free cash flow was decreased by $20.54M and operating cash flow was $-11.17M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -42.91M$ -7.57M$ -28.69M$ -18.23M$ -12.13M$ -9.60M
Investing Cash Flow
$ -67.61M$ -30.48M$ -248.00K$ -79.00K$ -586.00K$ -233.00K
Financing Cash Flow
$ 335.82M$ 116.41M$ 32.00K$ 27.77M$ 49.94M$ 10.77M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 497.86M$ 98.78M$ 20.42M$ 49.37M$ 39.87M$ 2.64M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
---$ 14.00K$ 29.00K$ 106.00K
Issuance Of Capital Stock
$ 125.00M$ 125.03M-$ 1.34M$ 55.90M$ 4.62M
Issuance Of Debt
----$ 500.00K$ 6.80M
Repayment Of Debt
----$ -451.00K$ -612.00K
Free Cash Flow
$ -52.16M$ -8.40M$ -28.94M$ -18.30M$ -12.72M$ -9.83M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Immunome Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis